Synergy Spine Solutions announced today that it received FDA premarket approval (PMA) for its Synergy Disc for 1-level indications at C3-C7.

Synergy Spine Solutions earned the FDA’s premarket approval for its Synergy Disc, according to a Feb. 27 news release. The device is approved for 1-level cervical disc replacement at C3 to C7 for ...

In the first couple of months of 2026, the artificial disc landscape is shaking up with developments in the technology, new adoption and research. 1. Armen Khachatryan, MD, performed the first U.S.

Highridge Medical announced today that it kicked off the limited U.S. launch of its activL lumbar disc system.

Highridge Medical, a leading privately held global spine company with a portfolio supported by extensive clinical evidence, today announced the U.S. limited launch of the activL(R) Lumbar Disc, along ...

We are excited to initiate the limited launch of the activL Lumbar Disc and expand access to this important treatment option for surgeons and their patients,” said Rebecca Whitney, CEO of Highridge ...

Use of GLP-1 agonists after anterior cervical discectomy and fusion may reduce the rates of pseudoarthrosis, dysphagia, revision surgery, sepsis and overall hospitalizations, according to results.“On ...

Subscribe to our weekly newsletter for the latest in industry news, expert insights, dedicated information security content and online events.